ArticlePLoS computational biology2026
Metal binding site alignment enables network-driven discovery of recurrent geometries across sequence-divergent proteins and drug off-targets.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal-binding sites (MBSs) are critical determinants of protein stability and biological function, yet methods for comparing their local binding environments lag behind those for whole-structure alignment. Here, we represent MBSs as atomic point clouds surrounding bound metal ligands and align them with a fine-tuned iterative closest point algorithm. Applying this framework to a redundancy-reduced collection of MBSs derived from all metalloproteins in the Protein Data Bank (PDB), we perform pairwise alignments across 23,342 sites to construct a similarity network of metal-binding environments. The resulting network topology recapitulates metal coordination chemistry and enzyme function: links are strongly enriched within metal types and across shared EC subclasses. Conserved metalloenzyme families form cohesive subnetworks; for example, the binuclear ureohydrolase domain appears as two tightly connected components that also capture atypical members such as the dinickel metformin hydrolase. We observe only a moderate global association between protein sequence and MBS geometry, yet many network links connect near-identical binding-site architectures across proteins with low sequence identity, consistent with either divergent evolution with local MBS conservation or candidate cases of molecular convergent evolution. Integrating network proximity with structural evidence of drug binding identifies drugs with enriched connectivity among their targets and predicts 528 drug-off-target combinations across 88 drugs and 151 human proteins, recovering both known off-targets (e.g., ADAM/ADAMTS for matrix metalloproteinase inhibitors) and proposing novel ones. The MBS network thus provides a scalable resource for probing metalloprotein evolution, functional convergence, and the structural basis of drug cross-reactivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.